Special Issue "Totally Intracorporeal Urinary Diversion after Robot-Assisted Radical Cystectomy for Muscle-Invasive Bladder Cancer"

A special issue of Current Oncology (ISSN 1718-7729). This special issue belongs to the section "Surgical Oncology".

Deadline for manuscript submissions: closed (30 September 2021).

Special Issue Editor

Dr. Takuya Koie
E-Mail Website
Guest Editor
Department of Urology, Gifu University Graduate School of Medicine, Gifu, Japan
Interests: muscle-invasive bladder cancer; prostate cancer; oligometastasis; robot-assisted surgery; intracorporeal urinary diversion; ileal neobladder; ileal conduit

Special Issue Information

Dear Colleagues,

Radical cystectomy (RC) remains the gold standard of treatment for muscle-invasive bladder cancer (MIBC). Minimally invasive surgical techniques have been widely used in a variety of surgical procedures. Of all of them, robot-assisted RC (RARC) has technical advantages over laparoscopic RC and emerged as a better alternative to open RC due to its possible reduction in estimated blood loss, blood transfusion rate, and quicker recovery of bowel function.

Although robotic surgery has advanced, experience in total intracorporeal urinary diversion (ICUD), including intracorporeal ileal conduit or neobladder reconstruction, remains limited. Most surgeons have performed the hybrid approach of RARC and extracorporeal urinary diversion since ICUD remains technically challenging. Although ICUD may have several potential advantages, the adoption of ICNB has been limited to high-volume academic institutions.

This Special Issue aims to summarize the utility and safety of RARC followed by totally ICUD in patients with MIBC at the authors’ institutions, especially focusing on perioperative morbidities and oncological outcomes.

Dr. Takuya Koie
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • robot-assisted radical cystectomy
  • intracorporeal urinary diversion
  • muscle-invasive bladder cancer
  • ileal conduit
  • ileal neobladder

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

Review
Incidence, Etiology, Prevention and Management of Ureteroenteric Strictures after Robot-Assisted Radical Cystectomy: A Review of Published Evidence and Personal Experience
Curr. Oncol. 2021, 28(5), 4109-4117; https://doi.org/10.3390/curroncol28050348 - 13 Oct 2021
Viewed by 232
Abstract
Benign ureteroenteric anastomosis strictures (UESs) are one of many critical complications that may cause irreversible disability following robot-assisted radical cystectomy (RARC). Previous studies have shown that the incidence rates of UES after RARC can reach 25.3%, with RARC having higher UES incidence rates [...] Read more.
Benign ureteroenteric anastomosis strictures (UESs) are one of many critical complications that may cause irreversible disability following robot-assisted radical cystectomy (RARC). Previous studies have shown that the incidence rates of UES after RARC can reach 25.3%, with RARC having higher UES incidence rates compared to open radical cystectomy. Various known and unknown factors are involved in the occurrence of UES. To minimize the incidence of UES after RARC, our group has standardized the procedure and technique for intracorporeal urinary diversion by applying the following five strategies: (1) wide delicate dissection of the ureter and preservation of the periureteral tissues; (2) gentle handling of the ureter and security of periureteral tissues at the anastomotic site; (3) use of indocyanine green to confirm good blood supply; (4) standardization of the ample ureteral spatulation length for Wallace ureteroenteric anastomosis through objective measurements; and (5) development of an institutional standardized procedure manual. This review focused on the incidence, etiology, prevention, and management of UES after RARC to bring attention to the incidence of this complication while also proposing standardized surgical procedures to minimize its incidence after RARC. Full article
Show Figures

Figure 1

Back to TopTop